Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, et al
FDA-approved GLP-1 receptor agonists include: - Semaglutide (Rybelsus, Ozempic, Wegovy) - Exenatide (Bydureon BCise, Byetta) - Lixisenatide (Adlyxin) - Lixisenatide/insulin glargine (Soliqua) - Liraglutide (Saxenda, Victoza) - Liraglutide/insulin degludec (Xultophy) - Dulaglutide (Trulicity) - Tirzepatide (Mounjaro) For example, Ozempic (semaglutide) is approved for type 2 diabetes, while Wegovy (also semaglutide) is approved for obesity and overweight conditions with related health concerns
Does Mochi Health Require a Video Visit
Are Vitamin B12 Injections Painful
Chan, A
In: Liu B, Lan H, Lv L, editors